Evolent Health (EVH) Tops Q3 EPS by 3c
Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
